Precision Oncology: A Global Perspective on Implementation and Policy Development

Area of Science:

• Oncology
• Genomics
• Health Policy

Background:

• Precision oncology (PO) is increasingly implemented globally, yet its full potential remains untapped.
• Numerous multifaceted barriers hinder the accessibility of PO benefits to broader patient populations.

Purpose of the Study:

• To identify and analyze the key challenges impeding the successful global implementation of precision oncology.
• To explore strategies for overcoming these barriers and promoting wider adoption of personalized cancer care.

Main Methods:

• A comprehensive review of scientific, technical, clinical, regulatory, economic, administrative, and health care policy factors.
• Analysis of infrastructure requirements, costs, personnel training, and alignment across stakeholders.

Main Results:

• Implementation faces scientific complexities, infrastructure deficits, and significant costs (R&D, testing, processing).
• A lack of administrative alignment with regulatory and payor acceptance, alongside outdated health care policies, poses major hurdles.
• Lower-income countries experience intensified adoption challenges.

Conclusions:

• Successful PO implementation requires addressing scientific, economic, and policy challenges, alongside administrative and regulatory alignment.
• Adapting health care policies to support personalized approaches and recognizing long-term gains over short-term costs are crucial.
• Growing awareness, successful examples, and advocacy are driving policy changes for more inclusive PO adoption.